Who We Are
Educating and Researching to Make a Difference
Director for The Center for Cell Reprogramming
Richard Schlegel, MD, PhD.
“It’s a dream of a scientist to be able to discover something in a laboratory that might not only be interesting to other scientists but have an impact on healthcare in the country, or in this case, the entire world…so it’s an exciting time!”
– Dr. Richard Schlegel, Chair of Department of Pathology and Director of Center for Cell Reprogramming, GUMC
Faculty
Seema Agarwal, PhD
Associate Professor
• In Vitro Cell Line Models
• Signaling Pathways
• Cell Model Systems
Ewa Krawczyk, PhD
Assistant Professor
• CRC Lab Manager
• E5 Protein
• CRC Cultures
Xuefeng Liu, MD
Professor
• Co-Director of Center for Cell Reprogramming
• Director of Telomeres & Cell Immortalization
• Scientific Director of Conditional Reprogramming Laboratory (CRL)
• Papillomarvirus Oncoproteins
Frank Suprynowicz, PhD
Assistant Professor
• Signaling Pathways
• CRC Biology
• CRC Technique
Hang Yuan, PhD
Associate Professor
Director of HPV Biology Program
Canine Papillomavirus
Vaccine Development
Abdul Mondal, PhD
Research Instructor
• Working with Dr. Xuefeng Liu
• Profile roles and modifications of p53 and CRCs
• Discovery of endogenous regulation of cellular senescence by natural p53 isoforms, D133p53 and p53β
Priscilla A. Furth, MD
Professor and Associate Dean
• Professor of Oncology & Medicine
• Associate Dean for Faculty Development
• Primary epithelial cell development
Jeffrey K. Huang, PhD
Assistant Professor
Department of Biology
Oligodendrocyte regeneration
Molecular signals in injury microenvironments
Christopher Albanese, PhD
Associate Professor
• Department of Oncology
• Growth Regulation of Cancer
• Development of High-Energy Imaging Technologies
Kevin T. FitzGerald, PhD
Associate Professor
• Department of Oncology
• Abnormal Gene Expression in Cancer
• Biomedical Research and Medical Genomics
Anton Wellstein, MD
Assistant Professor
• Oncology & Pharmacology
• Growth factor pleiotrophin and its signaling through the ALK kinase receptor
• Discovery of mechanisms of cancer metastasis and genes
Michael Johnson, PhD
Assistant Professor
• Department of Oncology
• Proteases, invasion and metastasis and the progression of breast cancer.
• The pharmacogenetics of drugs used in cancer therapy
Elena Silva, PhD
Professor
• Department of Biology
• Professor and Vice Dean
• Nervous System Development
Steve Singer, PhD
Professor
• Department of Biology
• Pathogenesis in Giardia and Giardia-host-microbiota interactions
• Innate immunity in Giardia infection, vaccine development, Giardia co-infections
Center Members
Sujata Choudhury
Research Associate II
• Working with Dr. Seema Agarwal
• Feeder free CRC system
• Role of p53 in normal/tumor CRCs and Rock1/Rock2 in cell reprogramming
Jie Lu
Research Assistant II
• Working with Dr. Ewa Krawczyk
• Processing tissues and using conditional reprogramming method to establish new cell lines
Zeeba Manavi
Research Technician II
• Working with Dr. Seema Agarwal
• Studying the role of EGFRvIII mutation in Glioblastoma Multiforme (GBM) cell lines in respect with known therapeutic drugs
Dan Zhou, MS
Research Assistant III
• Working with Dr. Hang Yuan
• Managing papillomavirus vaccine development and production
• 3D Air-liquid Interface culture to analyze HPV-related cancers in vitro
Jerry Xiao
Graduate Student
• Working with Dr. Seema Agarwal
• Exploring Circulating Tumor Cells and their role in tumor metastasis
Administrative
Haewon Park, MPH, CRA
Director of Business Operations
• Financial and Administrative Leadership
• Business outreach initiatives, commercial and research projects
• Marketing for CRC technology
Vera Simic, BS
Program Coordinator
• Lab Management
• Laboratory finances
• Maintaining and conditionally repgoramming tissue culture cells
Rachel Choi, CPA
Office Manager
• Office operations for Dr. Richard Schlegel
• Center for Cell Reprogramming website development